CONFIDENTIAL SEPARATION AGREEMENT & GENERAL RELEASEConfidential Separation Agreement • August 13th, 2024 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 13th, 2024 Company Industry JurisdictionTHIS CONFIDENTIAL SEPARATION AGREEMENT & GENERAL RELEASE (“Agreement”) is made and entered into by and between Curtis Lockshin (“Executive”), and Xenetic Biosciences, Inc. (the “Company”). Executive and Company are collectively referred to herein as the “Parties.”
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2024 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 13th, 2024 Company IndustryThis Amendment (the “Amendment”) to the Employment Agreement dated as of March 23, 2017 (the “Agreement”), between XENETIC BIOSCIENCES, INC., a Nevada corporation (the “Company”), and JAMES F. PARSLOW (the “Executive”) is dated as of June 18, 2024 (the “Execution Date”), and effective as of May 16, 2024 (the “Amendment Effective Date”). Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the Agreement.